Ichihara, Eiki http://orcid.org/0000-0002-2966-106X
Ochi, Nobuaki
Makimoto, Go
Kudo, Kenichiro
Harada, Daijiro
Ozaki, Yukinori
Nishio, Hiroshi
Tsuchihashi, Kenji
Miura, Yuji
Endo, Makoto
Yano, Shingo
Maruyama, Dai
Yoshinami, Tetsuhiro
Susumu, Nobuyuki
Takekuma, Munetaka
Motohashi, Takashi
Ito, Mamoru
Baba, Eishi
Uchino, Keita
Kimura, Takahiro
Kamiyama, Yutaro
Nakao, Shinji
Tamura, Shinobu
Nishimoto, Hitomi
Kato, Yasuhisa
Sato, Atsushi
Takano, Toshimi
Kubo, Toshio
Article History
Received: 14 December 2023
Accepted: 1 January 2024
First Online: 14 February 2024
Declarations
:
: Eiki Ichihara received honoraria from Eli Lilly and research funding from MSD, Ono Pharmaceutical, Jansen Pharma, and Takeda Pharmaceutical. Go Makimoto received honoraria from Kyowa Kirin. Yukinori Ozaki received honoraria from Daiichi-Sankyo, Pfizer, Chugai, Lilly, and Kyowa Kirin. Kenji Tsuchihashi received honoraria from Ono Pharmaceutical, Chugai Pharmaceutical, Taiho Pharmaceutical, and Novartis Pharma. Yuji Miura received honoraria from Ono Pharmaceutical, MSD, Takeda Pharmaceuticals, Eisai, Bristol Myers Squibb, and research funding from Ono Pharmaceutical and MSD. Shingo Yano received research funding from Otsuka Pharmaceutical. Dai Maruyama received honoraria from Ono Pharmaceutical, Janssen Pharma, Nippon Shinyaku, Eisai, Mundipharma, Kyowa Kirin, Chugai Pharmaceutical, Zenyaku, MSD, SymBio, Sanofi, AbbVie, Takeda Pharmaceutical, AstraZeneca, Bristol Myers Squibb, and Genmab, and research funding from Amgen, Astellas Biopharma, Novartis, Kyowa Kirin, Ono Pharmaceutical, Chugai Pharmaceutical, Janssen Pharma, Takeda Pharmaceutical, Otsuka Pharmaceutical, Sanofi, Astellas, Bristol Myers Squibb, AbbVie, Eisai, MSD, Taiho Pharmaceutical, AstraZeneca, Eli Lilly, and Genmab. Tetsuhiro Yoshinami received honoraria from Kyowa Kirin, Pfizer, Chugai Pharmaceutical, Eli Lilly, MSD, AstraZeneca, and Eizai. Takashi Motohashi received honoraria from AstraZeneca, Chugai Pharmaceutical, and Myriad Genetics. Eishi Baba received honoraria from Chugai Pharmaceutical and Daiichi-Sankyo, and research funding from Taiho Pharmaceutical and Chugai Pharmaceutical. Takahiro Kimura received honoraria from Sanofi. Shinji Nakao received honoraria from Kyowa Kirin. Atsushi Sato received honoraria from Chugai Pharmaceutical, and Taiho Pharmaceutical. Atsushi Sato received research funding from Chugai Pharmaceutical, and Taiho Pharmaceutical. Toshimi Takano received honoraria from Daiichi-Sankyo, Chugai Pharmaceutical, and Eli Lilly. Toshio Kubo received honoraria from Chugai Pharmaceutical.
: Not applicable.
: Not applicable.
: Not applicable.